BamSEC and AlphaSense Join Forces
Learn More

Neurogene Inc.

NASDAQ: NGNE    
Share price (1/6/25): $23.12    
Market cap (1/6/25): $343 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2022
Earnings Revised 08/09/22 Neoleukin Therapeutics, Inc., Q2 2022 Earnings Call, Aug 09, 2022 08/09/22 Other Revised 05/11/22 Neoleukin Therapeutics, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 01:20 PM 05/11/22 Earnings Revised 03/01/22 Neoleukin Therapeutics, Inc., Q4 2021 Earnings Call, Mar 01, 2022 03/01/22
CY 2021
Other Revised 05/13/21 Neoleukin Therapeutics, Inc. - Shareholder/Analyst Call 05/13/21 Other Revised 05/12/21 Neoleukin Therapeutics, Inc. Presents at BofA Securities 2021 Virtual Health Care Conference, May-12-2021 10:15 AM 05/12/21 Earnings Revised 03/25/21 Neoleukin Therapeutics, Inc., 2020 Earnings Call, Mar 25, 2021 03/25/21 Other Revised 01/14/21 Neoleukin Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-14-2021 01:30 PM 01/14/21
CY 2020
Earnings Revised 08/12/20 Neoleukin Therapeutics, Inc., Q2 2020 Earnings Call, Aug 12, 2020 08/12/20 Other Revised 06/23/20 Neoleukin Therapeutics, Inc. - Special Call 06/23/20 Other Revised 05/14/20 Neoleukin Therapeutics, Inc. Presents at BofA Securities 2020 Health Care Conference, May-14-2020 02:20 PM 05/14/20 Other Revised 05/05/20 Neoleukin Therapeutics, Inc. - Shareholder/Analyst Call 05/05/20 Earnings Revised 03/12/20 Neoleukin Therapeutics, Inc., 2019 Earnings Call, Mar 12, 2020 03/12/20
CY 2019
Other Revised 08/06/19 Aquinox Pharmaceuticals, Inc., Neoleukin Therapeutics, Inc - M&A Call 08/06/19